Skip to content
10-Q

Quarterly Report

SCOLR PHARMA, INC.

0001193125-11-306818

← back to feed
Filed
Nov 10, 2011 12:00 AM ET
Period of report
—

On SEC.gov

Filing index ↗

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2011 · Nov 1, 2011 49.82M sh
Operating Cash Flow Q3 2011 · Sep 30, 2011 −$2.87M
Operating Cash Flow Q3 2011 · Sep 30, 2010 −$2.43M
Cash And Equivalents Q3 2011 · Sep 30, 2011 $645K
Cash And Equivalents Q3 2011 · Dec 31, 2010 $1.89M
Cash And Equivalents Q3 2011 · Sep 30, 2010 $2.44M
Cash And Equivalents Q3 2011 · Dec 31, 2009 $1.18M
Stockholders Equity Q3 2011 · Sep 30, 2011 $1.51M
Stockholders Equity Q3 2011 · Dec 31, 2010 $3.04M
Current Liabilities Q3 2011 · Sep 30, 2011 $344K
Current Liabilities Q3 2011 · Dec 31, 2010 $658K
Total Liabilities Q3 2011 · Sep 30, 2011 $939K
Total Liabilities Q3 2011 · Dec 31, 2010 $817K
Current Assets Q3 2011 · Sep 30, 2011 $1.57M
Current Assets Q3 2011 · Dec 31, 2010 $2.59M
Total Assets Q3 2011 · Sep 30, 2011 $2.45M
Total Assets Q3 2011 · Dec 31, 2010 $3.86M
Sga Expense Q3 2011 · Sep 30, 2011 $497K
Sga Expense Q3 2011 · Sep 30, 2011 $1.82M
Sga Expense Q3 2011 · Sep 30, 2010 $643K
Sga Expense Q3 2011 · Sep 30, 2010 $1.82M
Rd Expense Q3 2011 · Sep 30, 2011 $71K
Rd Expense Q3 2011 · Sep 30, 2011 $615K
Rd Expense Q3 2011 · Sep 30, 2010 $257K
Rd Expense Q3 2011 · Sep 30, 2010 $853K
Net Income Q3 2011 · Sep 30, 2011 −$758K
Net Income Q3 2011 · Sep 30, 2011 −$2.52M
Net Income Q3 2011 · Sep 30, 2010 −$959K
Net Income Q3 2011 · Sep 30, 2010 −$2.49M
Operating Income Q3 2011 · Sep 30, 2011 −$603K
Operating Income Q3 2011 · Sep 30, 2011 −$2.46M
Operating Income Q3 2011 · Sep 30, 2010 −$869K
Operating Income Q3 2011 · Sep 30, 2010 −$2.39M
Revenue Q3 2011 · Sep 30, 2011 $12K
Revenue Q3 2011 · Sep 30, 2011 $204K
Revenue Q3 2011 · Sep 30, 2010 $124K
Revenue Q3 2011 · Sep 30, 2010 $513K
Capex Q3 2011 · Sep 30, 2010 $39K